Workflow
Mesoblast (MESO) - 2023 Q3 - Earnings Call Transcript
MESOMesoblast (MESO)2023-05-26 03:38

Mesoblast Limited (NASDAQ:MESO) Q3 2023 Earnings Conference Call May 25, 2023 6:30 PM ET Silviu Itescu – Chief Executive Officer Eric Rose – Chief Medical Officer Andrew Chaponnel – Interim Chief Financial Officer Edward Tenthoff – Piper Sandler Sami Corwin – William Blair John Hester – Bell Potter Thank you all for standing by. Hello and welcome to the Mesoblast Financial Results for the period ended March 31, 2023. An announcement and presentation have been lodged with the ASX and will also be available o ...